A Penn Medicine neurologist was awarded the 2025 John Dystel Prize for his research on immune cells and how they interact to ...
1d
Randomized 87 patients to date in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED) ---- Continuing enrollment ...
MELVILLE, N.Y., March 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback